134 related articles for article (PubMed ID: 34559693)
21. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
[No Abstract] [Full Text] [Related]
22. Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.
Castle SM; Salas N; Leveillee RJ
Urology; 2011 Apr; 77(4):792-7. PubMed ID: 21324512
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation of the T1a small renal mass: expanding beyond 3 cm.
Qiu J; Ballantyne C; Yeaman C; Lange M; Morgan J; Mershon JP; Richie I; DeNovio A; Clements MB; Krupski TL; Schenkman N; Lobo JM
Abdom Radiol (NY); 2023 Aug; 48(8):2695-2704. PubMed ID: 37212853
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
25. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
26. Utility of the RENAL Nephrometry Scoring System in Predicting Adverse Events and Outcomes of Percutaneous Microwave Ablation of Renal Tumors.
Li S; Huang J; Jang S; Schammel NC; Schammel C; Som A; El Khudari H; Devane AM; Gunn AJ
J Vasc Interv Radiol; 2022 Jun; 33(6):695-701. PubMed ID: 35311666
[TBL] [Abstract][Full Text] [Related]
27. CT-guided paravertebral block for microwave ablation of kidney tumors: a new technique.
Dubut J; Kastler B; Delabrousse E; Nardin C; Chenet J; Kleinclauss F; Aubry S
Abdom Radiol (NY); 2016 Jun; 41(6):1197-202. PubMed ID: 27108128
[TBL] [Abstract][Full Text] [Related]
28. Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index Score.
Kriegmair MC; Mandel P; Moses A; Lenk J; Rothamel M; Budjan J; Michel MS; Wagener N; Pfalzgraf D
Clin Genitourin Cancer; 2017 Apr; 15(2):248-255.e1. PubMed ID: 27594556
[TBL] [Abstract][Full Text] [Related]
29. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
30. Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study.
Men M; Ye X; Fan W; Zhang K; Bi J; Yang X; Zheng A; Huang G; Wei Z
Korean J Radiol; 2016; 17(6):864-873. PubMed ID: 27833402
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound-guided percutaneous microwave ablation of bilateral renal cell carcinomas: Focus upon safety and efficacy.
Zhang R; Qi E; Liang P; Cheng Z; Tan S; Han Z; Liu F; Yu J; Yu X
J Cancer Res Ther; 2021 Jul; 17(3):803-807. PubMed ID: 34269317
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Microwave Ablation for Malignant Renal Tumors: An Updated Systematic Review and Meta-Analysis of the Literature Since 2012.
Choi SH; Kim JW; Kim JH; Kim KW
Korean J Radiol; 2018; 19(5):938-949. PubMed ID: 30174484
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results.
Han ZY; Liang P; Yu XL; Cheng ZG; Liu FY; Yu J
Acta Radiol; 2015 Jan; 56(1):56-62. PubMed ID: 24526757
[TBL] [Abstract][Full Text] [Related]
34. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
35. R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected Cohort.
Borgmann H; Reiss AK; Kurosch M; Filmann N; Frees S; Mager R; Tsaur I; Haferkamp A
J Urol; 2016 Sep; 196(3):664-71. PubMed ID: 27091569
[TBL] [Abstract][Full Text] [Related]
36. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
[TBL] [Abstract][Full Text] [Related]
38. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of antegrade pyeloperfusion to protect the renal pelvis in kidney microwave ablation using an in vivo swine model.
Isfort P; Penzkofer T; Tanaka T; Bruners P; Westphal S; Kennes LN; Schmitz-Rode T; Kuhl CK; Mahnken AH
Invest Radiol; 2013 Dec; 48(12):863-8. PubMed ID: 24002078
[TBL] [Abstract][Full Text] [Related]
40. Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results.
Cornelis FH; Marcelin C; Bernhard JC
Diagn Interv Imaging; 2017 Apr; 98(4):287-297. PubMed ID: 28011104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
